Literature DB >> 2770120

Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers.

D M Lanese1, P S Alfrey, B A Molitoris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2770120     DOI： 10.1038/ki.1989.141

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  18 in total

Review 1.  Pharmacokinetics of continuous renal replacement therapy.

Authors:  M Schetz; P Ferdinande; G Van den Berghe; C Verwaest; P Lauwers
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

Review 2.  Principles of drug administration in renal insufficiency.

Authors:  Y W Lam; S Banerji; C Hatfield; R L Talbert
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

3.  [Drug dosing in extracorporeal therapy].

Authors:  J T Kielstein
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-05-22       Impact factor: 0.840

4.  Dosage recommendation of vancomycin during haemodialysis with highly permeable membranes.

Authors:  J Zoer; A M Schrander-van der Meer; W T van Dorp
Journal:  Pharm World Sci       Date:  1997-08

5.  Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration.

Authors:  F Thalhammer; P Schenk; H Burgmann; I El Menyawi; U M Hollenstein; A R Rosenkranz; G Sunder-Plassmann; S Breyer; K Ratheiser
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Comparison of the effects of three haemodialysis membranes on vancomycin disposition.

Authors:  J Alwakeel; T A Najjar; M J al-Yamani; S Huraib; A al-Haider; H Abu-aisha
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

Review 7.  Pharmacokinetic optimisation of vancomycin therapy.

Authors:  W G Leader; M H Chandler; M Castiglia
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

8.  Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.

Authors:  K Vance-Bryan; D R Guay; S S Gilliland; K A Rodvold; J C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

9.  Drug dosage in end-stage renal disease (ESRD) patients undergoing haemodialysis. A predictive study based on a microcomputer program.

Authors:  M V Mac-Kay; J Sanchez Burson; J Martinez-Lanao; A Dominguez-Gil
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

10.  Removal of vancomycin by high-flux hemodialysis membranes.

Authors:  J M Quale; J J O'Halloran; N DeVincenzo; R H Barth
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.